Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Belreca - Belgian Resources and Capital Company | BELR | Apr 22, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 22, 2024 | 2.00 | 0.00 |
Belysse Group N.V. | BELYS | Apr 22, 2024 | 0.82 | -5.17 |
Biocartis Group NV | BCART | Apr 22, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 22, 2024 | 0.02 | +5.10 |
Biotalys | BTLS | Apr 22, 2024 | 3.12 | -1.58 |
Boeing | BOEI | Apr 22, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 22, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 22, 2024 | 3.73 | +5.21 |
Brederode S.A. | BREB | Apr 22, 2024 | 111.00 | +1.09 |
Campine nv | CAMB | Apr 22, 2024 | 73.00 | +1.39 |
Candela Invest | CAND | Apr 22, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 22, 2024 | 13.26 | +0.15 |
Celyad Oncology SA | CYAD | Apr 22, 2024 | 0.32 | -5.74 |
Cenergy Holdings | CENER | Apr 22, 2024 | 7.46 | -1.71 |
Chevron | CHTEX | Apr 22, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 22, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 22, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 22, 2024 | 62.95 | +0.88 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 22, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 22, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 22, 2024 | 42.60 | +2.95 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 22, 2024 | 251.00 | +1.62 |
Compagnie d`Entreprises CFE SA | CFEB | Apr 22, 2024 | 7.55 | +2.03 |
Connect Group | CONN | Apr 22, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Apr 22, 2024 | 0.01 | 0.00 |
Cumulex NV | CLEX | Apr 22, 2024 | 1.15 | 0.00 |
CURETIS | CURE | Apr 22, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Apr 22, 2024 | 2.52 | +0.40 |
Deme Group N.V. | DEME | Apr 22, 2024 | 145.20 | +0.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.